Get started
Author

Miquel Granell

Observed names: Granell Miquel, M Granell, M. Granell, M. Granell Gorrochategui, Miguel Granell, Miguell Granell, Miquel Granell Gorrochategui
Observed institutions: Universitat Autònoma de Barcelona, Generalitat de Catalunya, Hospital de Sant Pau, Centre Hospitalier Universitaire de Toulouse, Josep Carreras Leukaemia Research Institute, Institut universitaire du cancer de Toulouse Oncopole, Complejo Hospitalario de Salamanca, Institut Català d'Oncologia, Hospital Clínic de Barcelona, Hospital Universitario Reina Sofía, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital Universitari Joan XXIII de Tarragona, Banc de Sang i Teixits, Hospital Universitari Germans Trias i Pujol, Hospital Universitari de Girona Doctor Josep Trueta, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario Ramón y Cajal, Institut de Recerca Sant Pau, Universitat de Barcelona
ORCID: 0000-0002-0366-3673
Observed ORCID: 0000-0002-0366-3673
OpenAlex ID: A5073739479
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
2012 · Laura Rosiñol, Albert Oriol, et al. · Blood · 486
PDF
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
2016 · Meletios A Dimopoulos, Judith Trotman, et al. · The Lancet Oncology · 240
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
2012 · María-Victoria Mateos, Albert Oriol, et al. · Blood · 144
PDF
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
2017 · Miquel Granell, Xavier Calvo, et al. · Haematologica · 128
PDF
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?
2014 · María-Victoria Mateos, Albert Oriol, et al. · Blood · 101
Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation
2006 · Miquel Granell, Alvaro Urbano-Ispizua, et al. · Experimental Hematology · 94
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
2024 · Sheri Skerget, Daniel Penaherrera, et al. · Nature Genetics · 91
PDF
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
2013 · B Paiva, M-B Vídriales, et al. · Leukemia · 91
Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic Malignancies
2006 · Francesc Fernández-Avilés, Enric Carreras, et al. · Journal of Clinical Oncology · 86
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
2022 · Fredrik H Schjesvold, Meletios-Athanasios Dimopoulos, et al. · The Lancet Haematology · 81
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial
2020 · Meletios Dimopoulos, Ramon Garcia Sanz, et al. · Blood Advances · 79
PDF
Darbepoetin‐alpha for the anaemia of myelofibrosis with myeloid metaplasia
2006 · Francisco Cervantes, Alberto Alvarez‐Larrán, et al. · British Journal of Haematology · 73
PDF
Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution
2005 · F Cervantes, A Alvarez-Larrán, et al. · Leukemia · 72
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
2006 · Mariano Monzo, Salut Brunet, et al. · Blood · 71
Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
2017 · L Rosiñol, A Oriol, et al. · Leukemia · 68
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
2006 · Miquel Granell, Alvaro Urbano-Ispizua, et al. · PubMed · 63
Recipient NOD2/CARD15 Variants: A Novel Independent Risk Factor for the Development of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation
2007 · Gerhard C. Hildebrandt, Miguell Granell, et al. · Transplantation and Cellular Therapy · 62
PDF
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
2010 · Margherita Maffioli, Mireia Camós, et al. · Leukemia Research · 58
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab
2015 · I García-Cadenas, N Castillo, et al. · Bone Marrow Transplantation · 57
Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
2020 · García-Cadenas Irene, Esquirol Albert, et al. · Bone Marrow Transplantation · 51
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis
2015 · Maria T. Cibeira, Albert Oriol, et al. · British Journal of Haematology · 49
Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma
2016 · María‐Victoria Mateos, Miguel Granell, et al. · British Journal of Haematology · 48
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
2022 · Meletios A Dimopoulos, Paul G Richardson, et al. · The Lancet Haematology · 47
Sonic hedgehog mRNA expression by real-time quantitative PCR in normal and tumor tissues from colorectal cancer patients
2005 · Mariano Monzo, Isabel Moreno, et al. · Cancer Letters · 40
Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation
2008 · Miquel Granell, Álvaro Urbano-Ispizua, et al. · Blood · 39
Works count: 114
Citation count: 3,103
H-index: 29
I10-index: 52
Year
Topic
Type